logo-mobile
  • About
    ▼
    • Mission
    • Technology
    • Team
    • Investors
    • Legal
  • Technology
    ▼
    • Technology Story
    • How It Works
    • Targeted Impact
    • Applications
  • Pipeline
    ▼
    • Development
    • Pipeline Objectives
    • Featured Publications
  • News
    ▼
    • Press Releases
    • Media Coverage
    • Events
  • Logo
  • Partners
  • Careers
    ▼
    • Open Positions
  • Contact
  • Search
  • About
    • Mission
    • Technology
    • Team
    • Investors
    • Legal
  • Technology
    • Technology Story
    • How It Works
    • Targeted Impact
    • Applications
  • Pipeline
    • Development
    • Pipeline Objectives
    • Featured Publications
  • News
    • Press Releases
    • Media Coverage
    • Events
  • Logo
  • Partners
  • Careers
    • Open Positions
  • Contact
  • Search

how can we help?

our partners

We’re expanding opportunities.
Our alphalex™ platform can expand treatable patient populations, enable new combinations, and power lifecycle management strategies via the creation of superior therapeutic options. Imagine what we can do when we work together.

existing partnerships

top stories

Read more about the impact of Cybrexa and alphalex in oncology.

SEE LATEST NEWS

press releases

Jun 6, 2017

Cybrexa Therapeutics Secures $6 Million in Series B Financing

Read more
Sep 21, 2017

Cybrexa Therapeutics Appoints Vishwas Paralkar, Ph.D. as Chief Scientific Officer

Read more
Oct 8, 2018

Cybrexa Therapeutics Appoints Keely Zipp as Vice President of Marketing

Read more

contact us

We’d love to hear from you

about

about

  • Mission
  • technology
  • team

Technology

Technology

  • technology story
  • targeted impact
  • how it works
  • applications

pipeline

pipeline

  • Development
  • Pipeline Objectives
  • Featured Publications

news

news

  • press releases
  • media coverage
  • events

partners

partners

careers

careers

  • open positions

Contact us

  • legal

© 2018 Cybrexa | All Rights Reserved